<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="14 days. A CMG from France (2017) recommended the addition of" exact="amoxicillin" post="in adults to cover for risk of L. monocytogenes"/>
 <result pre="N. meningitides is the most likely pathogen, and addition of" exact="cloxacillin" post="if associated skin or umbilical cord infection for all"/>
 <result pre="cefotaxime) 3rd generation-cephalosporin (ceftriaxone^ or cefotaxime) plus a penicillin (amoxicillin," exact="ampicillin" post="or penicillin) Aminoglycoside (gentamicin) plus a penicillin (amoxicillin or"/>
 <result pre="NNF Norsk Nevrologisk Forening Many CMGs recommended the addition of" exact="vancomycin" post="[2, 5, 34–37, 39, 40] alternatively rifampicin [2, 5,"/>
 <result pre="the addition of vancomycin [2, 5, 34–37, 39, 40] alternatively" exact="rifampicin" post="[2, 5, 37, 39] if there is suspicion of"/>
 <result pre="(USA) and NICE (UK) gave different advice. The first recommended" exact="vancomycin" post="to everyone except neonates (&amp;lt; 28 days old) [44], whereas the"/>
 <result pre="neonates (&amp;lt; 28 days old) [44], whereas the CMG by NICE recommended" exact="vancomycin" post="to all returning travellers or those with recent prolonged"/>
 <result pre="monocytogenes. Most of the European CMGs recommended the addition of" exact="vancomycin" post="or rifampicin if decreased susceptibility to penicillin or third-generation"/>
 <result pre="of the European CMGs recommended the addition of vancomycin or" exact="rifampicin" post="if decreased susceptibility to penicillin or third-generation cephalosporin is"/>
 <result pre="The CMG by IDSA aimed at all global settings recommended" exact="vancomycin" post="to everyone beyond neonatal age [44], which highlights the"/>
</results>
